NCT05399615

Brief Summary

Detection of bacterial and viral pathogens infection among hospitalized patients using breath analysis - feasibility study.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

December 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2022

Enrollment Period

5 months

First QC Date

May 24, 2022

Last Update Submit

May 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Discovery of exhaled breath biomarkers

    To evaluate the sensitivity, specificity, positive and negative predictive value of metabolomic biomarkers in exhaled breath samples as compared with pathogens biomarkers found in participants' blood and sputum samples.

    Through the study completion, up to 3 months.

Secondary Outcomes (1)

  • The association of exhaled biomarkers with inflammatory known biomarkers.

    Through the study completion, up to 3 months.

Study Arms (2)

Hospitalized Patients

EXPERIMENTAL

Patients hospitalized in internal ward at "Poriya" Medical Center

Diagnostic Test: VOX

Controls

EXPERIMENTAL

Healthy volunteers

Diagnostic Test: VOX

Interventions

VOXDIAGNOSTIC_TEST

Breath biopsy

ControlsHospitalized Patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 80 years at the time of consent
  • Capable of understanding written and/or spoken language
  • Able to provide informed consent
  • Negative results for SARS-CoV-2
  • Diagnosed with suspected respiratory infection

You may not qualify if:

  • Under guardianship or deprived of liberty
  • Pregnant or lactating woman
  • Not able to breathe through mask for 8 minutes
  • Intubated patients
  • Patients in critical condition
  • Diagnosed with hospital-acquired infection
  • Medical history of malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poriya Medical Center

Poria – Neve Oved, 1528001, Israel

Location

MeSH Terms

Conditions

Communicable Diseases

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Avi Peretz, PhD

    Poriya Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: parallel assignment
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2022

First Posted

June 1, 2022

Study Start

December 30, 2022

Primary Completion

May 31, 2023

Study Completion

July 31, 2023

Last Updated

May 16, 2023

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

No IPD

Locations